WACKER’s President & CEO, Christian Hartel, highlighted the projections outlined in the 2023 Annual Report during his address. The company anticipates sales for the current year to range between €6 billion and €6.5 billion, with Group EBITDA expected to fall…
In pursuit of its growth strategy for the BIOSOLUTIONS life-science division, WACKER is ramping up capacities in the biopharmaceutical realm, particularly for advanced therapies. Wacker Biotech US, a subsidiary specializing in fermentative production of plasmid DNA (pDNA), is broadening its…
Orica is advancing its commitment to sustainability by integrating fully lead-free detonator technology into its electronic blasting systems range. This innovation, which will encompass products like the eDev™ II Neo, uni tronic™ 600 Neo, and i-kon™ III Neo, maintains the…
Maximizing Blasting Efficiency: Optimizing Data Collection and Blasting Initiations for Precision” CIM Magazine recently engaged in a discussion with Daniel Andrew, Senior Product Manager at Orica Digital Solutions, and Ankit Saxena, Asia Marketing Manager, highlighting two of Orica’s latest innovations…
Solid Earnings Growth Driven by Core Business and Technological Advancements Highlights of the First Half of 2024: Orica, a global leader in blasting solutions, reported significant financial achievements in the first half of 2024. Key highlights include: CEO’s Perspective: Sanjeev…
In a recent discussion highlighted in Global Mining Review, Orica’s Washington Vilas Boas, specializing in Technical Services in Blasting Engineering, and Lucas Steffen from Kinross Gold’s Morro do Ouro mine in Brazil, shared insights into how Orica’s WebGen™ wireless initiating…
Eli Lilly Japan K.K. (headquartered in Kobe, Hyogo; led by Representative Director and President Simone Thomsen, hereinafter referred to as “Eli Lilly Japan”) and Mitsubishi Tanabe Pharma Corporation (headquartered in Osaka, Osaka; led by Representative Director Akihiro Tsujimura, hereinafter referred…
Santen Pharmaceutical Co., Ltd. (based in Osaka, henceforth referred to as Santen) and Mitsubishi Tanabe Pharma Corporation (also based in Osaka, henceforth referred to as Mitsubishi Tanabe Pharma) have recently inked a collaboration agreement aimed at jointly promoting Alesion® Eyelid…
Arkema Shareholders Approve Resolutions at Annual General Meeting On May 15, 2024, Arkema’s shareholders convened for their combined annual general meeting at the esteemed Théâtre des Sablons in Neuilly-sur-Seine. Presided over by Thierry Le Hénaff, the Chairman and Chief Executive…
Arkema has been selected by ProLogium, a Taiwanese leader in advanced battery technology, as a crucial development and supply partner for its upcoming gigafactory in France. On May 14th, Arkema and ProLogium held a letter of intent (LOI) exchange ceremony…
Financial Performance Update: Arkema Q1 2024 Arkema reported sales of €2.3 billion for the first quarter of 2024, marking a 7.3% decline compared to the same period last year. However, there was a slight increase of 2.7% in volume across…
Arkema has reached an agreement to acquire Dow’s flexible packaging laminating adhesives business, a major player in the adhesives sector for flexible packaging, with an annual revenue of approximately US$250 million. This strategic move is poised to significantly enhance Arkema’s…